RAN
0.005
66.7%
MGX
0.345
-26.6%
EVG
0.038
52%
EG1
0.052
-20%
TAS
0.033
43.5%
TMX
0.004
-20%
C7A
0.004
33.3%
YUG
0.044
-18.5%
HWK
0.04
33.3%
ALM
0.009
-18.2%
PKY
0.02
33.3%
FCT
0.014
-17.6%
WSR
0.008
33.3%
CR9
0.005
-16.7%
UNT
0.013
30%
OVT
0.005
-16.7%
ELT
0.36
28.6%
THR
0.015
-16.7%
TAT
0.054
28.6%
VAR
0.005
-16.7%
SKK
0.065
27.5%
IFG
0.011
-15.4%
AAJ
0.029
26.1%
ATR
0.915
-15.3%
OEL
0.005
25%
GTE
0.017
-15%
PIL
0.005
25%
RAU
0.255
-15%
PFT
0.037
23.3%
MDR
0.023
-14.8%
VHL
0.032
23.1%
CPM
0.053
-14.5%
VBS
0.17
21.4%
EXT
0.012
-14.3%
EMH
0.265
20.5%
GED
0.062
-13.9%
RBX
0.055
19.6%
YAR
0.013
-13.3%
LMG
0.043
19.4%
CR1
0.2
-13%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Arovella Therapeutics (ASX:ALA): TSN -The Stock Network

November 2023: Arovella Therapeutics (ASX:ALA) CEO & Managing Director Michael Baker presents for The Stock Network
.
Learn more about Arovella Therapeutics: https://www.arovella.com/